Half Year Report September 2021

A world without cervical cancer.

Quick links

Contact Us

The TruScreen Device

Markets & Distributors

Privacy Policy

Contact

info@truscreen.com

TruScreen Group Limited (NZX/ASX: TRU) is a New Zealand and Australian listed medical device company that has developed an AI-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. Unlike many cervical screening devices, that have only triage/adjunct functionality, the TruScreen device is registered as a stand alone primary screening tool.

© 2025 Truscreen Group Ltd. All rights reserved.